Navigation Links
DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
Date:4/18/2013

New York, NY (PRWEB) April 18, 2013

The drug safety advocates at DrugRisks.com are alerting of updated legal news on the site for patients who have taken the diabetes drug Actos. A jury could begin deliberations today in a trial accusing Takeda Pharmaceuticals of causing bladder cancer with their diabetes drug Actos***.

DrugRisks is designed to improve the safety of those taking popular prescription drugs like Actos by providing the latest warnings, recalls, studies and legal news. Visitors can determine if other patients are experiencing similar side effects and decide if they need legal advice.

The FDA and European Medicines Agency* have warned that taking Actos for longer than one year may be associated with an increased risk of bladder cancer. Regulators in France and Germany have even banned its use**.

DrugRisks has learned as many as 3,000 patients in the U.S. have filed an Actos lawsuit against Takeda Pharmaceuticals over allegations their drug caused bladder cancer***. The first trial is underway for Jack Cooper, a grandfather who is now terminally ill from the disease***.

Now, the resource center has added legal news showing lawyers are finishing their closing arguments and the jury could begin deliberations as soon as Tuesday or Wednesday this week. A decision is expected soon***.

Lawyers continue to help those diagnosed with bladder cancer after taking Actos file claims. Anyone affected is urged to contact the DrugRisks Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of drug injury litigation against large pharmaceutical companies, DrugRisks only recommends lawyers and law firms who have already handled Actos lawsuits.

Visit http://www.DrugRisks.com today for more information on Actos bladder cancer research, side effects and litigation news, or to speak with a lawyer.

*fda.gov/ForConsumers/ConsumerUpdates/ucm263431.htm#Actos; ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/07/hu an_pha_detail_000033.jsp&mid=WC0b01ac058001d126
**cbsnews.com/8301-504763_162-20070492-10391704.html
***bloomberg.com/news/2013-04-15/takeda-s-actos-diabetes-drug-tied-to-cancer-jury-is-told.html

Read the full story at http://www.prweb.com/releases/actos-lawsuit-news-2013/settlement-update/prweb10639079.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
2. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
3. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
4. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
5. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
6. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
7. Nia Vardalos Speaks Out on Adoption, Bolsters Legal Support for Abused Children
8. Tariq Drabu Supports Latest Campaign Against Illegal Tooth Whitening
9. Best Injury Lawyers? Time Magazine Includes McDonaldWorley.com Among Nations Legal Leaders
10. Gun retailers take a hard line on illegal firearm sales, UC Davis survey finds
11. Yasmin Blood-Clotting Lawsuits Update: Resource4thePeople Providing Legal Assistance as Concerns Rise Over Health Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2017)... ... May 19, 2017 , ... As a groundbreaking surgeon on ... importance of prostate cancer screenings. Early detection of the disease, he says, can make ... at Georgia Urology , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate ...
(Date:5/19/2017)... ... , ... CloSYS products which are marketed as the gentle giants of the ... gum health, which is linked to one’s overall health. Since 1991 when the CloSYS ... ways in which CloSYS products immediately helped eliminate bad breath as well as help ...
(Date:5/19/2017)... Santa Clara, CA (PRWEB) , ... May 18, 2017 , ... ... feature that allows sleep labs and physicians to independently dispense CPAP devices and supplies, ... DME orders, and sleep labs can dispense the devices. Device registration for daily usage ...
(Date:5/18/2017)... ... May 18, 2017 , ... Originally launched to market as the EPIK ... Due to the rapid expansion of their product line, the company believed it was ... Now, the HighQ brand will be any tablet product sold by EPIK Learning. ...
(Date:5/18/2017)... (PRWEB) , ... May 18, 2017 , ... ... Alliance, a Dulles, VA based educational and charitable organization which sponsors numerous programs ... for their third MURPH Challenge event over Memorial Day Weekend. , The ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... 4, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... data solutions, today announced that it is teaming up ... Technologies Limited to lower diabetes healthcare costs in ... card, which is available throughout all provinces and territories ... be eligible for additional savings when shopping for Dario ...
(Date:5/3/2017)... COUNTY, Calif. , May 3, 2017 /PRNewswire/ ... aspect of any hospital or healthcare facility. Commonly ... examination room is equipped with diagnostic imaging technology ... arteries of the heart. In these spaces, a ... angiography, catheterization, balloon angioplasty, percutaneous coronary intervention, congenital ...
(Date:5/3/2017)... Pa. , May 3, 2017  West ... in innovative solutions for injectable drug administration, announced ... Scientific Affairs and Technical Services, and Diane ... workshops and offering presentations focused on West,s expertise ... injectable products, as well as providing commentary on ...
Breaking Medicine Technology: